96949 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Angiogenesic factors; Angiogenin
BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE
#2MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#3BASE EDITING OF PCSK9 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE
#4A SKIN SUBSTITUTE COMPOSITION AND METHODS OF PRODUCING AND USING THE SAME
#5MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#6METHODS FOR TREATMENT OF OSTEOARTHRITIS
#7Targeted extracellular vesicles for delivery of therapeutics
#8MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS
#9Novel Angiopoietin 2, VEGF Dual Antagonists
#10AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF
#11BIOMARKER AND TREATMENT FOR VASCULAR COGNITIVE IMPAIRMENT AND RELATED CONDITIONS
#12CELL-BASED THERAPY FOR VIRAL DISEASES
#13Base editing of ANGPTL3 and methods of using same for treatment of disease
#14ANTIBODY-BOUND NANOPARTICLES
#15PEPTIDES FOR ANGIOGENIC THERAPY
#16REGENERATIVE CAR-T CELLS
#17ANTIVIRAL BIOMIMETIC PEPTIDES AND USES THEREOF
#18Base editing of PCSK9 and methods of using same for treatment of disease
#19CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES
#20PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE
#21ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE
#22AN AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF
#23SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES
#24PROMOTER FOR THE EXPRESSION OF GENES
#25PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE
#26GENETICALLY-ENGINEERED MESENCHYMAL STEM CELLS OVEREXPRESSING AOAH AND USES THEREOF
#27MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#28Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#29Artificially-manipulated neovascularization regulatory system
#30Peptides for angiogenic therapy
#31IN VIVO PRODUCTION OF PROTEINS
#32BMPRII POLYPEPTIDES AND USES THEREOF
#33Modified RNA encoding VEGF-A polypeptides, formulations, and uses relating thereto
#34TIE2 RECEPTOR ACTIVATION FOR GLAUCOMA
#35Synthetic truncated norrin protein
#36METHOD FOR EXTENDING HALF-LIFE OF PROTEIN
#37Peptides and compositions for treatment of joint damage
#38Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#39vNAR antibody which binds VEGF for use in dogs or cats
#40Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#41Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)
#42Angiopoietin 2, VEGF dual antagonists
#43Sustained delivery of angiopoetin-like 3 polypeptides
#44Mesenchymal stem cell differentiation
#45Methods for treatment of nephrotic syndrome and related conditions
#46Peptides and compositions for treatment of joint damage
#47Peptides for angiogenic therapy
#48Agent for promoting angiogenesis and methods and uses thereof
#49Rspondins as modulators of angiogenesis and vasculogenesis
#50In vivo production of proteins
#51TIE2 RECEPTOR ACTIVATION FOR GLAUCOMA
#52Compositions comprising PEDF-derived short peptides and uses thereof
#53MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
#54Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
#55Stimulation of Regenerative Processes and Factors by Noble Gases
#56Angiopoietin-based interventions for treating cerebral malaria
#57Retinal capillary regeneration with synthetic norrin protein
#58Peptides and compositions for treatment of joint damage
#59Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
#60POLYPEPTIDES TARGETING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 AND ALPHA V BETA 3 INTEGRIN
#61Mesenchymal stem cell differentiation
#62VEGF VARIANT POLYPEPTIDE COMPOSITIONS
#63Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)
#64Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
#65Modified Polynucleotides for the production of biologics and proteins associated with human disease
#66Promoter for the specific expression of genes in retinal endothelial cells
#67Humanized or affinity-matured anti ang-2 antibody and uses thereof
#68Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (VEGF)
#69Angiopoietin-based interventions for treating cerebral malaria
#70Methods of protecting a solid organ transplant tissue with angiopoietin-2 antibodies
#71ANTI-ANGIOGENIC VEGF-AX ISOFORM
#72Angiopoietin-like 4 and a method of its use in wound healing
#73Peptides and compositions for treatment of joint damage
#74BMPRII POLYPEPTIDES AND USES THEREOF
#75Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof
#76Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#77ANTI-OBESITY AND ANTI-DIABETIC EFFECTS OF ANGIOPOIETIN-LIKE 4 (ANGPTL4) FIBRINOGEN-LIKE DOMAIN
#78In vivo production of proteins
#79Angiopoietin 2, VEGF dual antagonists
#80Peptides and compositions for treatment of joint damage
#81TIE2 RECEPTOR ACTIVATION FOR GLAUCOMA
#82Methods and Pharmaceutical Composition for the Preservation of Vascular Endothelial Cell Barrier Integrity
#83BMPRII POLYPEPTIDES AND USES THEREOF
#84Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor (VEGF)
#85Peptides and compositions for treatment of joint damage
#86Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
#87Angiopoietin-based interventions for treating cerebral malaria
#88Human cytolytic fusion proteins
#89Peptides and compositions for treatment of joint damage
#90ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY
#91Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
#92Methods for treatment of nephrotic syndrome and related conditions
#93Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema
#94Quantitative ligandomics for systematic identification of therapeutic ligands
#95Treatment of disease
#96Peptides and compositions for treatment of joint damage
#97Mesenchymal stem cell differentiation
#98Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#99Modified polynucleotides for the production of proteins
#100PEPTIDE FOR INHIBITION OF BINDING BETWEEN ANGIOPOIETIN-2 AND INTEGRIN AND USE THEREOF
#101Methods, uses and compositions of Tie2 agonists
#102Methods of treating retinal disorders with anti-apelin antibodies
#103Angiopoietin-based interventions for treating cerebral malaria
#104Rspondins as modulators of angiogenesis and vasculogenesis
#105Peptides and compositions for treatment of joint damage
#106Conditional angiopoietin-1/angiopoietin-2 double knock-out mice with defective ocular drainage system
#107In vivo production of proteins
#108Recombinant placenta growth factor for treating Duchenne muscular dystrophy
#109Methods and Pharmaceutical Composition for the Preservation of Vascular Endothelial Cell Barrier Integrity
#110ANTI-ANGIOGENIC VEGF-AX ISOFORM
#111Humanized or affinity-matured anti Ang-2 antibody and uses thereof
#112Pharmaceutical composition for stimulation of angiogenesis
#113HYPOXIA REGULATED CONDITIONALLY SILENCED AAV EXPRESSING ANGIOGENIC INDUCERS
#114Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof
#115Angiopoietin-like 4 and a method of its use in wound healing
#116Modified polynucleotides for the production of cosmetic proteins and peptides
#117Antibodies directed to angiopoietin-2 and uses thereof
#118Polypeptides inhibiting neovascularization and uses thereof
#119In vivo production of proteins
#120Methods of treating cancer using angiogenin or an angiogenin agonist
#121Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin
#122Modified polynucleotides for the production of proteins
#123Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin
#124Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin
#125Method for preparing immobilized angiogenin
#126Angiogenin for treatment of glaucoma
#127Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin
#128Antagonist anti-Rspondin3 antibodies
#129Dual delivery system for heterologous antigens
#130Apelin antigen-binding proteins and uses thereof
#131Dual delivery system for heterologous antigens
#132Peptides and compositions for treatment of joint damage
#133Methods for treatment of nephrotic syndrome and related conditions
#134Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof
#135Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis
#136Treatment of disease
#137Angiopoietin derived peptides
#138Cell-protective peptides and uses thereof
#139Promoters exhibiting endothelial cell specificity and methods of using same
#140Anticancer fusion protein comprising trail and a growth factor receptor inhibitor
#141Antimicrobial angiogenin complexes (ANGex) and uses thereof
#142Methods for treatment of nephrotic syndrome and related conditions
#143RECOMBINANT MICROORGANISMS
#144Peptide having a vascularization-suppressing activity and a use therefor
#145Expression and export of angiogenesis inhibitors as immunofusins
#146FROG/TOAD conditionally silenced vectors for hypoxia gene therapy
#147Methods and uses of TIE2 binding and/or activating agents
#148Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis
#149RECOMBINANT MICROORGANISMS
#150METHODS AND PHARMACEUTICAL COMPOSITION FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY
#151Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#152TRANSGENIC NON-HUMAN ANIMALS
#153METHODS FOR IMPROVING ORAL DELIVERY
#154Methods of treating a disease or condition associated with abnormal angiogenesis
#155Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
#156Method for inducing angiogenesis in an infarcted heart by administering a coiled coil chimeric molecule
#157Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
#158PlGF-1 in homodimeric form
#159Promoters exhibiting endothelial cell specificity and methods of using same
#160Mesenchymal stem cell differentiation
#161Monoclonal antibodies against ANGPTL4
#162Etoposide and doxorubicin conjugates for drug delivery
#163Polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
#164Rspondin polypeptides as promoting factors of angiogenesis and vasculogenesis
#165Antibodies Directed to Angiopoietin-2 And Uses Thereof
#166VEGF antibodies comprising modular recognition domains
#167Multispecific antibody targeting and multivalency through modular recognition domains
#168Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin
#169Inhibitors of angiopoietin-like 4 protein, combinations, and their use
#170MODIFIED HUMAN THROMBOPOIETIN POLYPEPTIDE FRAGMENT AND MANUFACTURING METHOD THEREOF
#171Angiogenin complexes (ANGex) with lipid-based substrates and uses thereof
#172Method of treatment using organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1α
#173PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#174Angiopoietin derived peptides
#175PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME
#176Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis
#177Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins
#178Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#179DUAL DELIVERY SYSTEM FOR HETEROLOGOUS ANTIGENS
#180Angiogenin mutations and amyotrophic lateral sclerosis or motor neuron disease
#181Angiogenin-enriched milk fractions
#182Stable cell binding chimeric peptides
#183Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
#184Angiogenin and Amyotrophic Lateral Sclerosis
#185Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a
#186Web Traffic Analysis Tool
#187Monoclonal antibodies against ANGPTL4
#188Method of treating a cutaneous wound using a coiled coil chimeric molecule
#189METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#190Inhibition of placenta growth factor (PlGF) mediated metastasis and/or angiogenesis
#191REGULATION OF FUNCTION OF ANGIOPOIETIN
#192METHOD OF TREATING ABNORMAL ANGIOGENESIS VIA THE BAI FAMILY OF PROTEINS AND THEIR PROTEIN FRAGMENTS
#193SINGLE EXON GENES ENCODING FOR NOVEL BIO-ACTIVE PEPTIDES
#194Methods of using angiopoietin-like 4 protein to stimulate proliferation of pre-adipocytes
#195Polypeptides and polynucleotides encoding same
#196Process for the preparation of angiogenin
#197Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#198Methods for inhibition of angiogenesis and vasculogenesis via rspondin antagonists
#199Active antiangiogenic therapy
#200Angiogenin complexes (ANGex)
#201Promoters exhibiting endothelial cell specificity and methods of using same
#202Protein and production process and use thereof
#203Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
#204Methods for refolding proteins containing free cysteine residues
#205Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
#206REGULATION OF FUNCTION OF ANGIOPOIETIN
#207Keratinocytes expressing exogenous angiogenic growth factors
#208Chimeric Non-Human Animal and Use Thereof
#209Peptide compounds for treating obesity and insulin resistance
#210Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3
#211Muteins of placental growth factor type I, preparation method and application thereof
#212Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof
#213Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof
#214Antibodies Directed to Angiopoietin-2 and Uses Thereof
#215Angiogenin complexes (ANGex) and uses thereof
#216Antiangiogenic active immunotherapy
#217Immobilized angiogenin mixtures and uses thereof
#218Gene and protein associated with angiogenesis and endothelial cell-specific apoptosis
#219Anti-angiogenic compounds
#220CRBs as Modifiers of Branching Morphogenesis and Methods of Use
#221Chimeric CMP-Ang1 molecule
#222Antiobesity Drug
#223Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
#224Treatment of ALS and variants thereof consisting of primary lateral sclerosis (PLS) or spinal muscular atrophy (SMA)
#225Compositions related to pleiotrophin methods and uses thereof
#226Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4
#227Methods of using chimeric coiled coil molecule to treat ischemic disease
#228Polypeptide promoting vascular endothelial cell growth
#229Multifunctional and Multivalent Angiogenesis Inhibitors
#230Methods of treatment using specific binding agents of human angiopoietin-2
#231Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
#232Polypeptides and polynucleotides encoding same
#233Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
#234Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3
#235Methods of treatment using specific binding agents of human angiopoietin-2
#236Methods of treatment using specific binding agents of human angiopoietin-2
#237Inhibition of placenta growth factor (PLGF) mediated metastasis and/or angiogenesis
#238VARIANTS OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR, THEIR USES, AND PROCESSES FOR THEIR PRODUCTION
#239Methods of treatment using specific binding agents of human angiopoietin-2
#240Compositions and methods of using angiopoietin-like 4 protein
#241Method for treating ischemic diseases
#242Expression and export of angiogenesis inhibitors as immunofusins
#243Antibodies directed to angiopoietin-2 and uses thereof
#244Monoclonal antibodies against ANGPTL4
#245Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
#246Hepta-, octa-and nonapeptides having antiangiogenic activity
#247Method of screening antiobesity agents and animal model of obesity
#248Compositions and methods of using angiopoietin-like 4 protein antibody
#249Chimeric coiled coil molecules
#250Polypeptides and polynucleotides encoding same
#251Methods for modulating angiogenesis and apoptosis with apelin compositions
#252Variants of vascular endothelial cell growth factor, their uses, and processes for their production
#253Methods of inducing formation of functional and organized lymphatic vessels
#254RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
#255Peptides with wound healing activity
#256Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
#257Expressed ligand-vascular intercellular signaling molecule
#258Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#259Peptides with wound healing activity
#260Muteins of placental growth factor type 1, preparation method and application thereof
#261Active antiangiogenic therapy
#262Method of treatment using Tie2 ligand2
#263Glycosyltransferase GnT-V having neovascularization action
#264Hybrid plasmid pzzsa coding the synthesis of angiogenis of angiogenin protein and escherichia coli bl21(des) pzzsa strain as the the superoducer of the recombinant chimeric protein of human angiogenin
#265Promoters exhibiting endothelial cell specificity and methods of using same
#266Regulated angiogenesis genes and polypeptides
#267Expressed ligand-vascular intercellular signaling molecule
#268Novel FDRG protein and nucleic acid molecules and uses therefor
#269Production process of recombinant placental growth factor
#270Therapeutic protein and treatments
#271Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a